Procode AI Raises $10M to Automate Surgical Billing
Procode AI Lands $10M Series A to Expand AI-Driven Surgical Billing Platform
Procode AI has closed a $10 million Series A round to accelerate development of its AI-powered revenue cycle management platform focused on surgical billing workflows. The funding round, reportedly led by existing backers, positions the startup to expand its customer base among surgical centers, ASCs, and hospital OR departments struggling with complex procedure coding and denial management in an increasingly fragmented payor landscape.The Deal
Procode AI secured $10M in Series A capital to scale its surgical RCM platform. The company, which focuses on automating charge capture, coding accuracy, and claim submission workflows specific to surgical procedures, reportedly plans to invest heavily in product development and sales operations. Valuation details were not disclosed. The funding follows what the company describes as strong early adoption among mid-market surgical providers.What It Means for RCM
- Surgical billing gets specialized tooling: Unlike horizontal RCM platforms, Procode targets the specific pain points of surgical billing—complex bundling rules, real-time charge capture from the OR, and procedure-specific prior auth requirements. This vertical focus could pull surgical billing workflows away from traditional EHR and generic RCM vendors.
- AI-driven coding accuracy addresses a real bottleneck: Surgical billing relies heavily on manual coding reviews to avoid underbilling and denials. Automated coding assistance—if accurate—reduces dependency on experienced coders and accelerates claim submission, directly impacting AR velocity and denial rates.
- Market consolidation pressure: Established RCM vendors and EHR platforms will likely accelerate surgical billing product launches or seek acquisitions to compete. ASCs and surgical hospitals now have more choice, but integration friction may remain a key differentiator.
Market Context
Healthcare software funding has tilted toward AI-enabled RCM over the past 18 months as providers and payors grapple with rising denial rates and claim processing delays. Procode joins a crowded field of RCM-focused startups—including Wayflyer, Olive, and others—pursuing AI automation of revenue cycle tasks. The surgical specialization is notable; most well-funded RCM platforms remain horizontally positioned. Series A rounds in the $8–15M range suggest investor confidence in RCM automation as a defensible market, though exits remain uncertain and customer acquisition costs in healthcare remain high.Free Daily RCM Intelligence
Denial trends, payer policy moves, vendor intel — delivered every morning. Free.